Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration ...

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe ...

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Ideally, steroidal mineralocorticoid receptor antagonists such as spironolactone and eplerenone would be more widely prescribed; however, concerns of hyperkalemia and hormonal adverse effects ...

Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

(Balcinrenone + dapagliflozin) is under clinical development by AstraZeneca and currently in Phase II for Proteinuria.

Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online Dec. 9 in Arthritis Care & Research. Yumeko Kawano, M.D., from Brigham ...

The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, State Key Laboratory of Physical Chemistry of Solid Surfaces, Department of Chemistry, College of Chemistry and Chemical ...